The Oxford University Biotechnology Society, Oxford Entrepreneurs and the Oxford Science and Innovation Club invite you to join the groups’ inaugural Biotechnology Commercialisation event, "Oxford Founder-led Biotech: From Trainee to CXO”, taking place in person on Monday, November 22nd at 6:00PM! A reception will follow the panel.
Ross Upton, Co-Founder & CEO of Ultromics
Ross Upton is the founder and CEO of Ultromics, a University of Oxford spin-out technology company that has built an AI-based platform to predict patient outcomes in the field of cardiovascular imaging. The “EchoGo” platform is designed to improve both clinical outcomes in patients and save billions for healthcare systems worldwide. Ross has a broad scientific background having undertaken 4 degrees in the clinical sciences. During the last 3 years, he has built Ultromics to be one of the most prominent companies in healthcare AI, leading the creation of EchoGo which has received FDA clearance and qualified for reimbursement.
Ross has successfully raised multiple rounds of funding and was named on the 2019 Forbes 30 under 30 lists for science and healthcare.
Russ Tucker, Co-Founder & CTO of Ivy Farm
Ivy Farm’s co-founder and Chief Technology Officer, Russ Tucker, holds a PhD in Biomedical Engineering from Oxford University. Russ’ grandparents were butchers, but he read mechanical engineering as an undergraduate and subsequently qualified as a chartered accountant with PwC. He returned to academia at the University of Oxford, completing his PhD in biomedical engineering before joining the Boston Consulting Group as a management consultant, becoming a commercial and strategic adviser to supermarkets. Having witnessed first-hand the challenges faced by the UK’s advanced and super-efficient UK supermarkets when dealing with the inefficient and antiquated meat food chain, Russ wanted to create a British, sustainable food-technology company. By working with some of the best bioengineers and scientists in the UK, this company would develop proprietary intellectual property to deliver a break-through means of producing cultured meat – without the need for intensive farming. He approached his former PhD examiner, Professor Cathy Ye, with the idea and Ivy Farm was subsequently founded in 2019.
Marton Meszaros, COO of Novoic
Marton studied Medicine at Semmelweis University and Biochemical Engineering at UCL. He’s the first employee and COO of Novoic, where he leads the company’s clinical operations and commercial activities. Novoic is a clinical stage medical technology company developing diagnostic algorithms for the early detection of neurological and psychiatric disorders based on the way patients speak.